LDHA and bladder transitional cell carcinoma: This is achieved by accelerating the ubiquitin-mediated degradation of Axin1 and liberating the transcriptional expression of the key enzyme lactate dehydrogenase A (LDHA) to modulate the levels of glycolysis, allowing the malignant progression of BLCA.